Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

High-intensity brain stimulation to help with alcohol use disorder

Official title: High Intensity Alternating Current Stimulation as a Neuromodulation Therapy for Alcohol Use Disorder: A Pilot Study

Run by Shanghai Mental Health Center · NCT07227545 · Data updated 2026-11-12

This pilot study tests whether high-intensity transcranial alternating current stimulation (HI-tACS) can help reduce cravings and improve self-control in adults with alcohol use disorder.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment18 (estimated)
SponsorShanghai Mental Health Center
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedOctober 11, 2026
Main results expectedNovember 30, 2026
Study endsDecember 31, 2026
Registry record updatedOctober 16, 2026
Trial IDNCT07227545 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-60 with a DSM-5 diagnosis of Alcohol Use Disorder who can complete questionnaires and imaging procedures and have no contraindications to MRI.

Probably not a fit

Individuals with significant comorbid psychiatric or neurological conditions or those unable to tolerate MRI procedures may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This one-arm pilot study examines the preliminary effects of a two-week course of high-intensity transcranial alternating current stimulation (HI-tACS) on adults with alcohol use disorder. Participants will receive HI-tACS and undergo clinical assessments, EEG, and MRI before and after the intervention to explore changes in craving, self-regulation, decision-making, and brain activity. The goal is to generate initial clinical and mechanistic data to inform future research on HI-tACS as a neuromodulation therapy for AUD. The study also evaluates tolerability and safety in this population. MRI contraindications and other exclusion criteria ensure participant safety throughout the imaging protocol.

Why it matters

Potential benefit: If successful, HI-tACS could offer a non-invasive option to reduce cravings and improve cognitive-control in AUD.

How similar studies have gone: Previous neuromodulation studies in AUD have shown mixed results; this pilot will provide initial feasibility and mechanistic insights for HI-tACS in AUD.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Education level of junior high school or above, capable of completing questionnaires and behavioral tests;
* Aged 18-60 years;
* Meet DSM-5 diagnostic criteria for Alcohol Use Disorder;
* No abnormal findings on physical examination;
* Agree to participate in follow-up assessments;
* No contraindications for MRI scanning.

Exclusion criteria:

* Have impaired intelligence (Intelligence Quotient\<70);
* Prior tDCS or TMS treatment within the past 3 months;
* Contraindications for TMS therapy (e.g., intracranial metal implants, history of traumatic brain injury, skull defects, cardiac pacemakers, cardiovascular diseases, or epilepsy);
* Severe somatic diseases or major organ dysfunction;
* Psychiatric disorders per DSM-5 criteria (e.g., schizophrenia, schizoaffective disorder, intellectual disability, autism spectrum disorder, dementia, memory impairment, or other cognitive disorders).
* Psychiatric disorders per DSM-5 criteria (e.g., schizophrenia, schizoaffective disorder, intellectual disability, autism spectrum disorder, dementia, memory impairment, or other cognitive disorders).
* Diagnosis of other substance-related and addictive disorders or behavioral addictions.

Where it's running

  • Shanghai Mental Health Center
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.